Vir Biotechnology, Inc.

SEC 4 · Filed

0001628280-26-008984Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Feb 13, 2026

Sale by Sabatini Brent

Security
Common Stock
Code
S
Shares
1,530
Price per share
7.79
Structured facts
{
  "code": "S",
  "date": "2026-02-13",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer\u0027s tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.",
    "F2": "Includes 2,290 and 485 shares of common stock acquired by the Reporting Person on May 30, 2025 and November 28, 2025, respectively, pursuant to an employee stock purchase program."
  },
  "owners": [
    {
      "cik": "0002037272",
      "name": "Sabatini Brent",
      "roles": [
        "officer"
      ],
      "title": "SVP, Chief Accounting Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "47872",
  "price": "7.79",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "1530",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}